---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-103867"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2024-09-30T23:59:59+00:00"
generated_at: "2026-05-31T00:46:07.880217+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Quoin Pharma sets 2024 AGM for Dec 5; shareholder proposals due Oct 10

## Summary
- Annual meeting scheduled for December 5, 2024, more than 30 days after last year's anniversary.
- Shareholder proposals under Rule 14a-8 must be received by October 10, 2024 for inclusion in proxy.
- Universal proxy rule notice for director nominees also due by October 10, 2024.

## SEC filing metadata
- accession: 0001104659-24-103867
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2024-09-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465924103867/0001104659-24-103867-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465924103867/tm2425163d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-103867
- JSON: https://secwatch.observer/filing/0001104659-24-103867.json
- Plain text: https://secwatch.observer/filing/0001104659-24-103867.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.